VistaGen Therapeutics, Inc. (VTGN) analyst actions
Rating and price-target actions on VTGN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the VTGN overview →
7 measured VTGN analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Vistagen Therapeutics, Inc. (VTGN) And Encourages Shareholders to Reach Out | Press release | -0.52% | -3.83% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Vistagen Therapeutics, Inc. (VTGN) And Encourages Stockholders to Reach Out | Press release | -0.37% | -4.18% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Vistagen Therapeutics, Inc. (VTGN) And Encourages Shareholders to Reach Out | Press release | +2.35% | +4.16% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Vistagen Therapeutics, Inc. (VTGN) And Encourages Stockholders to Reach Out | Press release | -0.49% | -0.51% | |
| Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder | Press release | -0.66% | -1.98% | |
| Vistagen Initiates PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder | Press release | +2.36% | -4.42% | |
| Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2 | Press release | -2.59% | +0.00% |
Keep exploring
More VTGN: earnings → · SEC filings → · VTGN overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Gritstone bio, Inc. (GRTS) | 659 | -0.01% | 50% |
| Inovio Pharmaceuticals, Inc. (INO) | 658 | -0.29% | 43% |
| Quanterix Corporation (QTRX) | 657 | -0.21% | 46% |
| Encompass Health Corporation (EHC) | 656 | +0.01% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.